AbbVie, Inc. (ABBV)

206.00 -2.16 (-1.04%) USD  |  NYSE  |  May 05, 16:00
205.51 -0.49 (-0.24%) After-Hours: 20:00
More

AbbVie Free Cash Flow : 17.82B for Dec. 31, 2025

Free Cash Flow Chart

View Free Cash Flow for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Amgen, Inc. 8.597B
Biogen, Inc. 2.316B
Gilead Sciences, Inc. 9.456B
Johnson & Johnson 17.80B
Regeneron Pharmaceuticals, Inc. 3.791B

Free Cash Flow Related Metrics

Free Cash Flow Per Share (Quarterly) 2.756
Free Cash Flow to Equity (Quarterly) 5.447B
Free Cash Flow to Firm (Quarterly) 5.404B
Free Cash Flow Yield 4.88%